InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,008.24
(
-1.25%
)
US TECH 100
16,798.40
(
-1.54%
)
Dow Jones
37,867.23
(
-1.54%
)
Brent Oil
86.66
(
-0.65%
)
Bitcoin
63,587.89
(
-1.08%
)
Post# of 251591
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 117
Posts 20162
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: None

Wednesday, 06/28/2017 12:29:30 PM

Wednesday, June 28, 2017 12:29:30 PM

Post# of 251591
OMER these results are what generated the buzz in the Renal community .

http://investor.omeros.com/phoenix.zhtml?c=219263&p=irol-newsArticle_Print&ID=2273493

and why I'm not selling but rather using this short attack to buy more .

There is no approved treatment for Iga Nephropathy ...its the most common primary glomerular disease worldwide and 40% of those with it, eventually progress to ESRD ( dialysis )

JMO
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up